News

nFusion Capital provided an $8 million factoring line for a mug and baby bottle distributor that, while preparing itself for a sale, needed short-term financing to clean up its balance sheet and provide working capital.

Commercial Finance Partners (CFP) funded four new factoring facilities.

First Trust Advisors finalized the timing of the closing of the reorganization First Trust/abrdn Global Opportunity Income Fund with and into abrdn Income Credit Strategies Fund.

Summit Park recapitalized Thrust Flight, a provider of professional flight training services, in partnership with founder and CEO Patrick Arnzen, management and AltitudeX Aviation. The transaction marks Summit Park’s fifth platform investment in its fourth fund, Summit Park IV.

Doral Renewables, a U.S. developer, owner and operator of renewable energy and storage projects, closed a $400 million minority equity investment by Dutch pension APG on behalf of Dutch pension fund ABP.

Equipment from Strauss Brands’ Franklin plant is available in an online auction by Tiger Group and Barliant Auctions. The timed auction of excess assets closes on Thursday, Sept. 26, at 10 a.m. CST. Bidding opens on Friday, September 20, at...

A new survey from Grant Thornton shows that professionals in the mergers and acquisitions (M&A) space are predicting an increase in deal volume, even with the uncertainty of the looming U.S. presidential election.

Sound Point Capital Management, a global alternative credit manager with more than $45 billion in assets under management, closed Sound Point U.S. Direct Lending Fund III, its largest direct lending fund to date, with $1.2 billion of total investable capital.

Versana closed a $26 million capital raise with the addition of Barclays as an investor in its centralized, real-time digital data platform. Existing investors Bank of America, Citi, Deutsche Bank, J.P. Morgan, Morgan Stanley and Wells Fargo also participated in...

SSG Capital Advisors served as the investment banker to Eiger BioPharmaceuticals in the sale of Lonafarnib and Lambda, and associated clinical assets, to Eiger InnoTherapeutics. The sale was effectuated through a chapter 11 section 363 process.